| |
| |
|
| Insider
Information: |
Requadt Scott |
| Relationship: |
Former Chief Executive... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
608,405 |
|
|
Indirect Shares
|
449,766 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,058,171 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ESSA Pharma Inc |
EPIX |
Director |
2023-11-06 |
30,002 |
|
0 |
Premium* |
|
|
Tourmaline Bio |
TRML |
Former Chief Executive... |
2023-07-03 |
578,403 |
2023-07-03 |
449,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EPIX |
ESSA Pharma Inc |
Director |
– • – |
2023-11-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,500) |
30,002 |
0 |
- |
|
| EPIX |
ESSA Pharma Inc |
Director |
– • – |
2023-10-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(17,502) |
42,502 |
0 |
- |
|
| TRML |
Tourmaline Bio |
Former Chief Executive Officer |
– – – |
2023-07-03 |
4 |
D |
$3.08 |
$36,301 |
D/D |
(11,786) |
578,403 |
0 |
- |
|
| TRML |
Tourmaline Bio |
Chief Executive Officer |
• • – |
2022-12-30 |
4 |
A |
$0.87 |
$3 |
D/D |
4 |
590,193 |
0 |
- |
|
| TRML |
Tourmaline Bio |
Chief Executive Officer |
• • – |
2022-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
590,189 |
0 |
- |
|
| TRML |
Tourmaline Bio |
Chief Executive Officer |
• • – |
2022-07-29 |
4 |
B |
$4.25 |
$167,374 |
D/D |
39,382 |
508,680 |
2.81 |
- |
|
| TRML |
Tourmaline Bio |
Chief Executive Officer |
• • – |
2022-07-28 |
4 |
B |
$4.25 |
$13,133 |
D/D |
3,090 |
469,298 |
2.81 |
- |
|
| TRML |
Tourmaline Bio |
Chief Executive Officer |
• • – |
2022-07-26 |
4 |
B |
$4.24 |
$23,439 |
D/D |
5,528 |
466,208 |
2.81 |
- |
|
| TRML |
Tourmaline Bio |
Chief Executive Officer |
• • – |
2022-07-22 |
4 |
B |
$3.75 |
$35,412 |
D/D |
9,444 |
460,680 |
2.81 |
- |
|
| TRML |
Tourmaline Bio |
Chief Executive Officer |
• • – |
2021-12-31 |
4 |
A |
$13.00 |
$19,110 |
D/D |
1,470 |
451,236 |
0 |
- |
|
| TRML |
Tourmaline Bio |
See RemarksOfficer |
• • – |
2021-05-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
449,766 |
|
- |
|
| TRML |
Tourmaline Bio |
See RemarksOfficer |
• • – |
2021-05-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
449,766 |
|
- |
|
| EPIX |
ESSA Pharma Inc |
Director |
– • – |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
